607 related articles for article (PubMed ID: 23663980)
1. Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.
Matsumoto M; Funami K; Oshiumi H; Seya T
Prog Mol Biol Transl Sci; 2013; 117():487-510. PubMed ID: 23663980
[TBL] [Abstract][Full Text] [Related]
2. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
Seya T; Matsumoto M; Ebihara T; Oshiumi H
Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
[TBL] [Abstract][Full Text] [Related]
3. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
4. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Toll-like receptor 3 pathway in endosomal signaling.
Matsumoto M; Funami K; Tatematsu M; Azuma M; Seya T
Methods Enzymol; 2014; 535():149-65. PubMed ID: 24377923
[TBL] [Abstract][Full Text] [Related]
6. Comparative and phylogenetic analyses of three TIR domain-containing adaptors in metazoans: implications for evolution of TLR signaling pathways.
Wu B; Xin B; Jin M; Wei T; Bai Z
Dev Comp Immunol; 2011 Jul; 35(7):764-73. PubMed ID: 21362440
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
9. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor and RIG-I-like receptor signaling.
Kawai T; Akira S
Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
[TBL] [Abstract][Full Text] [Related]
12. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
13. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
14. Antiviral responses induced by the TLR3 pathway.
Matsumoto M; Oshiumi H; Seya T
Rev Med Virol; 2011 Mar; 21(2):67-77. PubMed ID: 21312311
[TBL] [Abstract][Full Text] [Related]
15. [Progress of research on TLRs-mediated signaling pathway].
Chang XT; Nian XF; Wang ZH
Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):340-6. PubMed ID: 22242400
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
17. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
18. 14-3-3-zeta participates in TLR3-mediated TICAM-1 signal-platform formation.
Funami K; Matsumoto M; Obuse C; Seya T
Mol Immunol; 2016 May; 73():60-8. PubMed ID: 27058640
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA.
Funami K; Sasai M; Ohba Y; Oshiumi H; Seya T; Matsumoto M
J Immunol; 2007 Nov; 179(10):6867-72. PubMed ID: 17982077
[TBL] [Abstract][Full Text] [Related]
20. Innate immune responses: crosstalk of signaling and regulation of gene transcription.
Zhong B; Tien P; Shu HB
Virology; 2006 Aug; 352(1):14-21. PubMed ID: 16753195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
